Tracy R. Daniels-Wells

university of california

H指数:32

被引数:4,305

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy of an Fc-silent antibody targeting the apical domain of human transferrin receptor 1 in transgenic mouse models of Junín virus infection

靶向人转铁蛋白受体1顶端结构域的Fc沉默抗体在转基因小鼠模型中针对胡宁病毒感染的疗效

Antiviral Research

IF4

2026-04-280

PRE

hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse models

hu128.1，一种靶向转铁蛋白受体1的人源化抗体，可阻断异种移植小鼠模型中的红白血病生长。

HAEMATOLOGICA

IF7.9

2024-12-120

Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief Communication

JOURNAL OF IMMUNOTHERAPY

IF2.9

2022-04-260

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections

NATURE COMMUNICATIONS

IF15.7

2022-01-286

OAAI

IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-12-034

Markov, Spas Dimitrov; Caffrey, Thomas C.; O'Connell, Kelly A.; Grunkemeyer, James A.; Shin, Simon; Hanson, Ryan; Patil, Prathamesh P.; Shukla, Surendra K.; Gonzalez, Daisy; Crawford, Ayrianne J.; Vance, Krysten E.; Huang, Ying; Eberle, Kirsten C.; Radhakrishnan, Prakash; Grandgenett, Paul M.; Singh, Pankaj K.; Madiyalakan, Ragupathy; Daniels-Wells, Tracy R.; Penichet, Manuel L.; Nicodemus, Christopher F.; Poole, Jill A.; Jaffee, Elizabeth M.; Hollingsworth, Michael A.; Mehla, Kamiya

Targeting TfR1 with the ch128.1/IgG1 Antibody Inhibits EBV-driven Lymphomagenesis in Immunosuppressed Mice Bearing EBVthorn Human Primary B-cells

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-06-224

Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-03-17156

OAAI

Efficacy of antibodies targeting TfR1 in xenograft mouse models of AIDS-related non-Hodgkin lymphoma

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Targeting transferrin receptor 1 (TfR1) with the ch128.1/IgG1 antibody inhibits Epstein-Barr virus (EBV) driven lymphoproliferative growth and lymphomagenesis in immunosuppressed mice bearing human B cells

CANCER RESEARCH

IF16.6

2020-08-151

PRE

Combination therapy with an antibody specific for transferrin receptor 1 (ch128.1/IgG1) and bortezomib or lenalidomide results in increased survival in an in vivo model of human multiple myeloma

CANCER RESEARCH

IF16.6

2020-08-151

PRE

An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication

JOURNAL OF IMMUNOTHERAPY

IF2.9

2019-10-3011

OAAI

Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein

CYTOKINE

IF3.7

2019-08-015

OAAI

Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk

CANCER RESEARCH

IF16.6

2019-03-1564

OAAI

Sun, Tao; Patil, Rameshwar; Galstyan, Anna; Klymyshyn, Dmytro; Ding, Hui; Chesnokova, Alexandra; Cavenee, Webster K.; Furnari, Frank B.; Ljubimov, Vladimir A.; Shatalova, Ekaterina S.; Wagner, Shawn; Li, Debiao; Mamelak, Adam N.; Bannykh, Serguei I.; Patil, Chirag G.; Rudnick, Jeremy D.; Hu, Jethro; Grodzinski, Zachary B.; Rekechenetskiy, Arthur; Falahatian, Vida; Lyubimov, Alexander V.; Chen, Yongmei L.; Leoh, Lai S.; Daniels-Wells, Tracy R.; Penichet, Manuel L.; Holler, Eggehard; Ljubimov, Alexander V.; Black, Keith L.; Ljubimova, Julia Y.

Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells

FRONTIERS IN IMMUNOLOGY

IF5.9

2019-02-1833

OAAI

An IgG1 version of the anti-TfR1 antibody ch128.1 shows significant antitumor activity against different xenograft models of multiple myeloma

CANCER RESEARCH

IF16.6

2018-07-010

PRE

A potential new autologous mast cell cancer immunotherapy

CANCER RESEARCH